Cerveau Technologies announced a research collaboration with Banner Health to support various research projects studying the stages of Alzheimer’s disease and other neurodegenerative diseases. These research projects will utilize an investigational imaging agent (MK-6240) to be used in positron emission tomography (PET) scans for assessing the status and progression of neurofibrillary tangles (NFTs) in the brain. NFTs made up of …
Recent Comments